Loading provider…
Loading provider…
Pediatrics Physician in Philadelphia, PA
NPI: 1154477834Primary Employer
Chca Hematology & Oncology
chop.edu
HQ Phone
Get MD Theodore's Phone Numberphone_androidMobile
Get MD Theodore's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
PA State Medical License
FL State Medical License
2021
TX State Medical License
2013 - 2027
PA State Medical License
2009 - 2026
DE State Medical License
2022 - 2025
NJ State Medical License
2022 - 2025
MD State Medical License
2021 - 2024
NC State Medical License
2021 - 2024
VA State Medical License
2022 - 2024
NY State Medical License
2021 - 2023
CO State Medical License
2007 - 2009

American Board of Pediatrics
Pediatric Hematology-Oncology
Children's Hospital of Philadelphia
Fellowship • Pediatric Hematology/Oncology
2009 - 2012
UCSF School of Medicine
medschool.ucsf.edu
Medical School
Until 2005
University of Colorado
Residency • Pediatrics
2005 - 2009
Authors: Noah Federman, Alexander Edward Drilon, Leo Mascarenhas, Ramamoorthy Nagasubramanian
Journal: Lancet Oncol
Publication Date: 2020-02-24
The promise of TRK inhibitors in pediatric cancers with NTRK fusions.
Authors: Emily R Blauel, Theodore W Laetsch
Publication Date: 2022-04
Authors: Daniel Landsburg, Mary Horowitz, Joseph Rosenthal, Monalisa Ghosh, Steven Margossian, Stephan Grupp, Manali Kamdar, Cameron Turtle, Matthew Frigault, Frederick Locke, Miguel Perales, Sarah Nikiforow, Michael Pulsipher, Rayne Rouce, Amy Keating, Marcelo Pasquini, Kevin Curran, Joshua Sasine, Dana Salzberg
Journal:
Lead Sponsor: Children's Hospital of Philadelphia
Collaborators: United States Department of Defense
Intervention / Treatment: PROCEDURE: Whole body scan
Lead Sponsor: Bayer
Intervention / Treatment: DRUG: Larotrectinib (Vitrakvi, BAY2757556)
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: BIOLOGICAL: CTL019